Oxygenta [OXYGENTAPH] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison
Oxygenta
BSE
Loading...
Divi's Laboratories
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Oxygenta wins in 6 metrics, Divi's Laboratories wins in 10 metrics, with 0 ties. Divi's Laboratories appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Oxygenta | Divi's Laboratories | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 444.32 | 70.79 | Divi's Laboratories |
| Price-to-Book Ratio | N/A | 10.93 | N/A |
| Debt-to-Equity Ratio | -2.43 | 0.03 | Oxygenta |
| PEG Ratio | N/A | 2.67 | N/A |
| EV/EBITDA | -28.18 | 51.97 | Oxygenta |
| Profit Margin (TTM) | -13.45% | 23.89% | Divi's Laboratories |
| Operating Margin (TTM) | -50.72% | 25.60% | Divi's Laboratories |
| EBITDA Margin (TTM) | N/A | 25.60% | N/A |
| Return on Equity | 40.16% | 14.64% | Oxygenta |
| Return on Assets (TTM) | -12.44% | 12.94% | Divi's Laboratories |
| Free Cash Flow (TTM) | $-87.89M | $2.15B | Divi's Laboratories |
| Dividend Yield | N/A | 0.91% | N/A |
| 1-Year Return | 99.93% | 24.14% | Oxygenta |
| Price-to-Sales Ratio (TTM) | 2.69 | 16.95 | Oxygenta |
| Enterprise Value | $3.70B | $1,592.76B | Divi's Laboratories |
| EV/Revenue Ratio | 3.31 | 16.50 | Oxygenta |
| Gross Profit Margin (TTM) | 4.52% | 60.33% | Divi's Laboratories |
| Revenue per Share (TTM) | $31 | $363 | Divi's Laboratories |
| Earnings per Share (Diluted) | $-2.86 | $87.08 | Divi's Laboratories |
| Beta (Stock Volatility) | 0.56 | 0.27 | Divi's Laboratories |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Oxygenta vs Divi's Laboratories Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Oxygenta | -0.12% | -9.18% | -27.15% | -10.28% | -0.25% | -5.93% |
| Divi's Laboratories | 2.05% | -1.70% | -9.87% | -8.00% | 4.71% | -0.74% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Oxygenta | 99.93% | 193.27% | 211.39% | 211.39% | 211.39% | 211.39% |
| Divi's Laboratories | 24.14% | 68.03% | 84.18% | 436.36% | 1,518.78% | 8,163.19% |
Performance & Financial Health Analysis: Oxygenta vs Divi's Laboratories
| Metric | OXYGENTAPH | DIVISLAB |
|---|---|---|
| Market Information | ||
| Market Cap | ₹3.01B | ₹1.64T |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 8,480 | 557,925 |
| 90 Day Avg. Volume | 4,887 | 372,093 |
| Last Close | ₹80.55 | ₹6,151.50 |
| 52 Week Range | ₹35.80 - ₹133.50 | ₹4,828.95 - ₹7,071.50 |
| % from 52W High | -39.66% | -13.01% |
| All-Time High | ₹133.50 (Jun 09, 2025) | ₹7,071.50 (Jul 08, 2025) |
| % from All-Time High | -39.66% | -13.01% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.20% | 0.14% |
| Quarterly Earnings Growth | 3.69% | 0.27% |
| Financial Health | ||
| Profit Margin (TTM) | -0.13% | 0.24% |
| Operating Margin (TTM) | -0.51% | 0.26% |
| Return on Equity (TTM) | 0.40% | 0.15% |
| Debt to Equity (MRQ) | -2.43 | 0.03 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹-7.15 | ₹563.87 |
| Cash per Share (MRQ) | ₹0.03 | ₹132.86 |
| Operating Cash Flow (TTM) | ₹-89,042,000 | ₹19.67B |
| Levered Free Cash Flow (TTM) | ₹-102,983,000 | ₹21.91B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.91% |
| Last 12-Month Dividend | N/A | ₹60.00 |
Valuation & Enterprise Metrics Analysis: Oxygenta vs Divi's Laboratories
| Metric | OXYGENTAPH | DIVISLAB |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 444.32 | 70.79 |
| Forward P/E | N/A | 109.49 |
| PEG Ratio | N/A | 2.67 |
| Price to Sales (TTM) | 2.69 | 16.95 |
| Price to Book (MRQ) | N/A | 10.93 |
| Market Capitalization | ||
| Market Capitalization | ₹3.01B | ₹1.64T |
| Enterprise Value | ₹3.70B | ₹1.59T |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.31 | 16.50 |
| Enterprise to EBITDA | -28.18 | 51.97 |
| Risk & Other Metrics | ||
| Beta | 0.56 | 0.27 |
| Book Value per Share (MRQ) | ₹-7.15 | ₹563.87 |
Financial Statements Comparison: Oxygenta vs Divi's Laboratories
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | OXYGENTAPH | DIVISLAB |
|---|---|---|
| Revenue/Sales | ₹494.67M | ₹24.10B |
| Cost of Goods Sold | ₹472.30M | ₹9.56B |
| Gross Profit | ₹22.37M | ₹14.54B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹-14.00M | ₹6.17B |
| EBITDA | ₹-13.51M | ₹8.48B |
| Pre-Tax Income | ₹-37.99M | ₹7.33B |
| Income Tax | ₹-16.46M | ₹1.88B |
| Net Income (Profit) | ₹-21.53M | ₹5.45B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | OXYGENTAPH | DIVISLAB |
|---|---|---|
| Cash & Equivalents | ₹17,000 | ₹4.15B |
| Total Current Assets | ₹309.43M | ₹100.81B |
| Total Current Liabilities | ₹858.47M | ₹14.52B |
| Long-Term Debt | ₹215.22M | ₹20.00M |
| Total Shareholders Equity | ₹-256.41M | ₹149.69B |
| Retained Earnings | N/A | ₹134.00B |
| Property, Plant & Equipment | ₹368.30M | ₹3.19B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | OXYGENTAPH | DIVISLAB |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | OXYGENTAPH | DIVISLAB |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 8,480 | 557,925 |
| Average Daily Volume (90 Day) | 4,887 | 372,093 |
| Shares Outstanding | 36.98M | 265.47M |
| Float Shares | 2.30M | 120.74M |
| % Held by Insiders | 0.79% | 0.52% |
| % Held by Institutions | 0.00% | 0.29% |
Dividend Analysis & Yield Comparison: Oxygenta vs Divi's Laboratories
| Metric | OXYGENTAPH | DIVISLAB |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹60.00 |
| Last 12-Month Dividend Yield | N/A | 0.91% |
| 3-Year Avg Annual Dividend | N/A | ₹50.00 |
| 3-Year Avg Dividend Yield | N/A | 0.70% |
| 3-Year Total Dividends | N/A | ₹150.00 |
| Ex-Dividend Date | N/A | Jul 25, 2025 |